Chronic intranasal insulin does not affect hepatic lipid content in healthy male subjects: a randomised, double-blind, placebo-controlled trial

被引：0
|
作者：
Scherer, T. [1 ]
Wolf, P. [1 ]
Smajis, S. [1 ]
Gaggini, M. [2 ]
Gastaldelli, A. [2 ]
Krssak, M. [1 ,3 ]
Krebs, M. [1 ]
机构：
[1] Med Univ Vienna, Dept Med 3, Div Endocrinol & Metab, Vienna, Austria
[2] Inst Clin Physiol, Pisa, Italy
[3] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, High Field MR Ctr, Vienna, Austria
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
152
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [21] A double-blind, placebo-controlled, single subcutaneous dose escalation trial of oncostatin-M in healthy male subjects.
    Palmisano, M
    Summerill, RS
    Hagerty, DT
    Damle, B
    Stewart, MB
    BLOOD, 1999, 94 (10) : 56B - 56B
  • [22] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
  • [23] Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
    McCarey, DW
    McInnes, LB
    Madhok, R
    Hampson, R
    Scherbakova, O
    Ford, I
    Capell, HA
    Sattar, N
    LANCET, 2004, 363 (9426): : 2015 - 2021
  • [24] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF OMEPRAZOLE ON CHARACTERISTICS OF GASTRIC-EMPTYING IN HEALTHY-SUBJECTS
    RASMUSSEN, L
    OSTERJORGENSEN, E
    QVIST, N
    KRAGLUND, K
    HOVENDAL, C
    PEDERSEN, SA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1991, 5 (01) : 85 - 89
  • [25] Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial
    Derosa, G.
    Salvadeo, S. A. T.
    Ferrari, I.
    Gravina, A.
    Mereu, R.
    D'Angelo, A.
    Palumbo, I.
    Randazzo, S.
    Maffioli, P.
    DIABETOLOGIA, 2010, 53
  • [26] Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial
    Bishop, Nick
    Adami, Silvano
    Ahmed, S. Faisal
    Anton, Jordi
    Arundel, Paul
    Burren, Christine P.
    Devogelaer, Jean-Pierre
    Hangartner, Thomas
    Eva Hosszu
    Lane, Joseph M.
    Lorenc, Roman
    Makitie, Outi
    Munns, Craig F.
    Paredes, Ana
    Pavlov, Helene
    Plotkin, Horacio
    Raggio, Cathleen L.
    Loreto Reyes, Maria
    Schoenau, Eckhard
    Semler, Oliver
    Sillence, David O.
    Steiner, Robert D.
    LANCET, 2013, 382 (9902): : 1424 - 1432
  • [27] A randomised, double-blind, placebo-controlled trial of a topical cream for osteoarthritis of the knee
    Cohen, MM
    Wolfe, R
    Mai, T
    Lewis, D
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3421 - 3421
  • [28] Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial
    Simental-Mendia, Luis E.
    Guerrero-Romero, Fernando
    NUTRITION, 2019, 58 : 7 - 10
  • [29] Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD
    Matthys, Heinrich
    Pliskevich, Dina A.
    Bondarchuk, Oleksandr M.
    Malek, Fathi A.
    Tribanek, Michael
    Kieser, Meinhard
    RESPIRATORY MEDICINE, 2013, 107 (05) : 691 - 701
  • [30] Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
    Mullen, Michael
    Jin, Xu Yu
    Child, Anne
    Stuart, A. Graham
    Dodd, Matthew
    Aragon-Martin, Jose Antonio
    Gaze, David
    Kiotsekoglou, Anatoli
    Yuan, Li
    Hu, Jiangting
    Foley, Claire
    Van Dyck, Laura
    Knight, Rosemary
    Clayton, Tim
    Swan, Lorna
    Thomson, John D. R.
    Erdem, Guliz
    Crossman, David
    Flather, Marcus
    LANCET, 2019, 394 (10216): : 2263 - 2270
12345